Chiesi groupNews - Page 1

Oak Hill Bio and Chiesi enrol first European patient in bronchopulmonary dysplasia treatment study

Oak Hill Bio and Chiesi Group have launched a study of a revolutionary bronchopulmonary dysplasia treatment for extremely premature infants.

Chiesi NICU campaign and documentary to raise awareness for premature births

A Chiesi neonatal intensive care unit (NICU) campaign and documentary to raise awareness for premature births.

Chiesi places 23rd in 2024 World’s Best Workplaces™ List

This is the first time that Chiesi has been included in the GPTW global list, making it the first Italian company to achieve this honour.

Chiesi launches ‘The Impulse’ to drive innovation and collaboration in healthcare

The Impulse aims to tackle some of the biggest challenges facing patients, the planet, and people today. Read more here.

Chiesi Group’s new Biotech Center of Excellence brings the future of medicine to Parma

Chiesi Group is making a strategic investment of € 400 million to establish its new Biotech Center of Excellence in Parma.

Chiesi Group releases 2023 sustainability report

Chiesi, an international biopharmaceutical group, has published its 2023 sustainability report. Find out more.

Laura Vergani joins Chiesi Group to lead global communications & public affairs

Laura Vergani has joined Chiesi Group this week as Senior Vice President of Global Communications & Public Affairs.

Innovation News Network - Free Digital eBook Library

Innovation News Network - Global Innovation Partners

Special Reports

Partner News

Special Reports Cont'd

Partner News Cont'd